Pacific Biosciences of California, Inc. (PACB)
2.21
-0.14
(-5.96%)
USD |
NASDAQ |
Jan 16, 16:00
2.13
-0.08
(-3.62%)
After-Hours: 07:26
Pacific Biosciences of California Enterprise Value: 1.068B for Jan. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 141.47B |
| Intellia Therapeutics, Inc. | 1.035B |
| Twist Bioscience Corp. | 2.380B |
| Beam Therapeutics, Inc. | 2.244B |
| Bruker Corp. | 9.128B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -38.00M |
| Revenue (Quarterly) | 38.44M |
| Total Expenses (Quarterly) | 76.44M |
| EPS Diluted (Quarterly) | -0.1263 |
| Gross Profit Margin (Quarterly) | 39.20% |
| Profit Margin (Quarterly) | -98.85% |
| Earnings Yield | -98.45% |
| Normalized Earnings Yield | -102.72 |